Safety and Feasibility of Human Umbilical Cord Mesenchymal Stem Cell-Derived Secretome in the Treatment of Liver Cirrhosis: a Comprehensive Evaluation of Fibrosis Reduction, Immunomodulation, and Hepatic Regeneration: a Single Center, Randomized, Phase I Clinical Trial

Clinical trial NCT06629909 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06629909
Sponsor: Baermed
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Liver Cirrhosis

Start date: 2024-12-01
Primary completion: 2025-10-31
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.